This approach unveils the potential of oligonucleotides as a ray of hope in mitigating the neurotoxic impact of TDP-43 aberrations, providing a novel and targeted strategy in ALS treatment. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.